CIK 0001287098
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522210438
- Phone
- +1 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, Global Sales & Marketing sold 29,133 shares at an average $5.72 ($166,517)
- 4 Open-market sale President and CEO sold 30,000 shares at an average $5.72 ($171,553)
- 4 Open-market sale President and CEO sold 30,000 shares at an average $5.08 ($152,430)
- 4 Open-market sale EVP, Global Sales & Marketing sold 29,133 shares at an average $5.08 ($148,051)
- 4 Open-market sale EVP, Global Sales & Marketing sold 29,133 shares at an average $5.81 ($169,303)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, Global Sales & Marketing sold 29,133 shares at an average $6.92 ($201,670)
- 4 Open-market sale EVP, Global Sales & Marketing sold 29,133 shares at an average $6.46 ($188,165)
- 4 Open-market sale 10% owner sold 735,786 shares at $6.15 ($4,525,084)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 9 · 164 filings